Pregnancy and Naltrexone Pharmacotherapy

Area of Science:

• Obstetrics and Gynecology
• Pharmacology
• Addiction Medicine

Background:

• A pregnant patient with a history of opioid use disorder (OUD) and prior cesarean deliveries is seeking prenatal care.
• The patient is currently treated with extended-release naltrexone injection, having previously shown poor adherence to methadone and buprenorphine.
• She expresses concerns about the safety of naltrexone for her fetus and requires a plan for postoperative pain management.

Purpose of the Study:

• To evaluate the safety and management of extended-release naltrexone injection in pregnant women with opioid use disorder.
• To address patient concerns regarding fetal outcomes and maternal pain control during pregnancy and postpartum.

Main Methods:

• This is a case report focusing on a single patient's clinical scenario.
• Review of the patient's medical history, including OUD treatment, previous pregnancies, and current medication regimen.
• Discussion of potential risks and benefits of extended-release naltrexone during gestation and strategies for pain management.

Main Results:

• The case highlights the clinical decision-making process for managing OUD in pregnancy with extended-release naltrexone.
• It underscores the importance of individualized treatment plans considering patient history and adherence.
• The management of postoperative pain in this context requires careful consideration of opioid-sparing techniques.

Conclusions:

• Extended-release naltrexone may be a viable option for pregnant women with OUD, but requires careful monitoring.
• Comprehensive management strategies are essential for addressing both maternal OUD and fetal safety.
• Effective postoperative pain management plans are crucial for patients on naltrexone.